Updated hourlyHourly refreshWed, Sep 9, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare · Education
(PR-inside.com) Reaccreditation through 2036 affirms the program's continued compliance with APA Standards of Accreditation while continuing its distinctive Catholic-Christian approach to clinical psychology. STERLING, VA / ACCESS Newswire / September 2, 2026 / Divine Mercy University's Institute for the Psychological Sciences (IPS), home to the university's Doctor of Psychology (Psy.D.) in Clinical Psychology program, has received 10-year reaccreditation from the American Psychological Association (APA), the maximum period available. This reaccreditation affirms the strength of the Psy.D. program and its continued compliance with the APA Standards of Accreditation. The milestone also underscores the program's commitment to rigorous practitioner-scholar training within its distinctive Cath
Sep 2 · 10:00·PR-Inside
Healthcare
American Lung Association's campaign, in partnership with Olympus, offers roadmap to help patients gain control over their health with nodule management and early detection CHICAGO, Sept. 2, 2026 /PRNewswire/ -- One of the greatest opportunities to improve lung cancer outcomes is the...
Sep 2 · 09:03·mlpr-prnewswire-wire
Healthcare
Research Highlights: A large study in Denmark suggests that people who were diagnosed with a variety of psychiatric disorders after traumatic events were more likely to have increased future cardiovascular risks, such as non-fatal heart attack and stroke or cardiovascular death, compared to those who did not have mental health issues after a traumatic event. While alcohol abuse after trauma was the top psychiatric predictor for future cardiovascular risks among both men and women, mood disorders, such as depression, were more prominent predictors among women who experienced trauma. DALLAS - September 2, 2026 ( NEWMEDIAWIRE ) - Mental health conditions, such as posttraumatic stress disorder (PTSD), substance abuse, depression and anxiety, can develop after people experience trauma. These co
Sep 2 · 09:00·NewMediaWire
Healthcare
WUXI, China, Sept. 2, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY), a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regulatory clearance from China's National Medical Products Administration (NMPA) to initiate a...
Sep 2 · 09:00·mlpr-prnewswire-wire
Healthcare
-Texas Cardiac Arrhythmia Institute en St. David's Medical Center primeros en EE.UU. en participar en un ensayo clínico de un innovador sistema de mapeo y ablación por campo pulsado AUSTIN, Texas, 2 de septiembre de 2026 /PRNewswire/ -- El Texas Cardiac Arrhythmia Institute (TCAI) en St....
Sep 2 · 07:37·PR Newswire
Healthcare
Edmonton, Alberta--(Newsfile Corp. - September 2, 2026) - Resetting Lives Inc., founded by Nigerian-born, Canada-based transformation strategist Coach Ayomide Adeyina, is expanding its work around personal development and whole-person wellbeing with the development of the Executive Health & Life Audit™, a proprietary self-awareness framework designed for high-achieving executives and leaders to examine the broader factors influencing how they live, lead and make decisions.The initiative reflects...
Sep 2 · 07:07·mlpr-newsfile
SaaS · Healthcare
New program combines brain science, mental health and spiritual principles to help churches build healthier communities COSTA MESA, Calif., Sept. 2, 2026 /PRNewswire/ -- Amen University, the online brain health education platform founded by double board-certified psychiatrist and 20-time...
Sep 2 · 07:00·PR Newswire
Healthcare
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, proudly announces the addition of hematologist-oncologist, Dr. Rebecca Zweifler. Beginning September 1, 2026, Dr. Zweifler will be practicing at NYCBS’s office located at 500 W 181st Street, 9th Floor, New York, NY 10033. “We are excited to welcome Dr. Zweifler to New York Cancer & Blood [PR.com]
Sep 2 · 07:00·PR.com
AI · Healthcare
BERLIN, Germany, September 02, 2026--Vara has received CE certification under the EU Medical Device Regulation (Class IIb) for autonomous triage in organised breast cancer screening – the first breast AI certified anywhere to report screening examinations as normal without radiologist review.
Sep 2 · 06:00·mlpr-businesswire
Healthcare
1 Estimation non auditée préparée par la Direction sur la base des informations disponibles à la date du présent communiqué de presse. La prochaine publication financière de la Société portera sur les comptes du premier semestre 2026 et interviendra en octobre 2026. 2 La date PDUFA correspond à la date cible à laquelle la Food and Drug Administration (FDA) américaine prévoit d’achever la revue d’une demande d’autorisation de mise sur le marché (NDA) et de rendre sa décision, conformément au Prescription Durg User Fee Act (PDUFA).
Sep 2 · 05:30·GlobeNewswire
Healthcare
Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research and innovation initiative launched to address environmental emissions and exposure concerns related to per- and polyfluoroalkyl substances (PFAS) in the pharmaceutical and medical sectors. As part of the project, IBA will co-lead the work on end-of-life and waste-management technologies, bringing its electron beam and Rhodotron ® expertise to the assessment of PFAS destruction solutions.
Sep 2 · 05:00·GlobeNewswire
Finance · Healthcare
MARSEILLE, France, September 02, 2026--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor meetings at the following conference:
Sep 2 · 05:00·mlpr-businesswire